این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Physical Chemistry Research، جلد ۱۱، شماره ۴، صفحات ۷۰۷-۷۲۳
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی Towards Screening and Repurposing of Approved Drugs for the Treatment of COVID-19 Using Molecular Docking
چکیده انگلیسی مقاله Molecular docking is applied to investigate interactions between 1638 approved drugs and the COVID-19 virus proteins (Spike, non-structural proteins NSP3, NSP7, NSP8, NSP9, NSP10, NSP12 (two binding sites), NSP15, NSP16, and NSP10-NSP16 complex), and the human angiotensin converting enzyme 2, ACE2 protein, and its Spike@ACE2 complex. Structures of these approved drugs are fully optimized with the universal force field (UFF) and their lowest energy conformations are used for docking on the (co)crystallized structures of the target proteins taken from the protein data bank (PDB). The docking procedure is performed in two stages and the results are evaluated based on four ranking indices or docking scores which measure comparative affinities of the studied drugs towards the COVID-19 virus proteins. Details of the positions, orientations and interactions of the first three highest-rank drugs in the binding pocket of the COVID-19 Spike, NSP7 and the human ACE2 proteins (as representatives) are visualized, analyzed and discussed. Based on the results of this molecular docking study, Vazegepant, Dasabuvir, Vitamin E, Fosamprenavir, Raltegravir, Canagliflozin, Biliverdin and Imatinib drugs can be considered promising for further molecular mechanics/dynamics simulations and then clinical studies, to accomplish the screening task.
کلیدواژه‌های انگلیسی مقاله COVID-19,Spike and NSP proteins,Repurposing,Molecular docking,ACE2,Ranking indices
نویسندگان مقاله Marzieh Soltani |
Department of Bioinformatics and Systems Biology, School of Advanced Technologies in Medicine, Isfahan University of Medical Sciences, Isfahan, 81746-73461, I. R. Iran

Soroush Sardari |
Drug Design and Bioinformatics Unit, Department of Medical Biotechnology, Biotechnology Research Center, Pasteur Institute of Iran, Tehran 13169-43551, I. R. Iran

Hassan Sabzyan |
Department of Chemistry, University of Isfahan, Isfahan 81746-73441, I. R. Iran

Fahimeh Ghasemi |
Department of Bioinformatics and Systems Biology, School of Advanced Technologies in Medicine, Isfahan University of Medical Sciences, Isfahan, 81746-73461, I. R. Iran. Bioinformatics Research Center, School of Pharmacology and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, 81746-73461, I. R. Iran

نشانی اینترنتی https://www.physchemres.org/article_161623_0b413f7237b250ecb3b4aeb2e1503004.pdf
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات